Sharemaestro Newsreel

A1ZW87 Bond Coupon Profile — Rate & Payments

This article provides a coupon profile for the A1ZW87 bond issued by Cencora, Inc., which has a coupon rate of 4.25% and matures on March 1, 2045. It details the bond's interest payment overview, including the current coupon rate and the next scheduled payment …

McKesson's Q1 2027 Earnings: What to Expect

Henry Schein (HSIC) Q4 2024 earnings summary

Henry Schein's Q4 2024 results revealed stable dental and medical markets, significant operating income from high-growth businesses, and the completion of its 2022–2024 BOLD+1 plan. The company reported Q4 2024 GAAP diluted EPS of $0.74, non-GAAP diluted EPS of $1.19, and projected 2025 sales …

Cosmos Health shareholders approved Series B preferred stock designation at annual meeting

Cosmos Health shareholders held their annual meeting on July 15, 2026, where they approved several key proposals. These included ratifying the appointment of the independent registered public accounting firm, adopting the 2026 Equity Omnibus Plan, and authorizing the designation and issuance of 100,000 shares …

Henry Schein stock stays anchored by 2025 sales and margin trends

Henry Schein's stock performance is currently framed by its 2025 financial figures, including $12.7 billion in sales (a 2.3% reported decline, but a 2.6% increase in constant currency), $774 million in operating income, and diluted EPS of $2.94. These metrics provide a clear baseline …

Do GLP-1 Margin Fears Reveal Something Deeper About McKesson’s (MCK) Defensive Revenue Story?

Concerns about GLP-1 cash-pay trends and upcoming specialty drug loss-of-exclusivity events are pressuring McKesson's stock, raising questions about potential margin compression for drug distributors. Despite these worries, McKesson is viewed as a resilient healthcare distributor with strong customer relationships and recurring revenue streams. The …

Cosmos Health (NASDAQ: COSM) wins backing for Series B preferred and equity plan

Cosmos Health Inc. (NASDAQ: COSM) shareholders approved the designation and issuance of 100,000 shares of Series B Preferred Stock and the company's 2026 Equity Omnibus Plan at their annual meeting on July 15, 2026. Stockholders also elected six directors and ratified the independent registered …

Nasdaq grants Cellyan Biotechnology (Nasdaq: HKPD) bid-price extension

Cellyan Biotechnology (HKPD) has been granted an additional 180-day grace period by Nasdaq until January 11, 2027, to regain compliance with the minimum $1.00 bid price requirement. The company must maintain a closing bid price of at least $1.00 per share for ten consecutive …

Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period

Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) has received an additional 180-day grace period from Nasdaq, extending until January 11, 2027, to regain compliance with the minimum $1.00 closing bid price requirement. The company must maintain a closing bid price of at least $1.00 for …

Cellyan Biotechnology Must Reach $1 Bid Price by Jan. 11

Cellyan Biotechnology (Nasdaq: HKPD) announced it has received a 180-day extension from Nasdaq, until January 11, 2027, to regain compliance with the $1.00 minimum closing bid price requirement. To meet this, the company's Class A ordinary shares must close at $1.00 or higher for …

Cellyan Biotechnology Stock Sinks 21% After Hours: Here's What Happened

Cellyan Biotechnology Co. Ltd (NASDAQ: HKPD) shares dropped over 20% in after-hours trading after the company announced it received an additional 180-day compliance period from Nasdaq to meet the minimum $1.00 bid price requirement. The company must maintain a closing bid price of at …

McKesson Jumps 5.5% Amid Sector-Wide Rally

McKesson Corporation's stock surged 5.5%, closing at $840.34, as the medical distribution sector experienced a powerful, broad-based rally. This synchronized movement, which saw peers like COR, ACH, and EXHI also post significant gains, suggests strong institutional demand or a rotation of capital into the …

Henry Schein stock hits 52-week high at 89.34 USD By Investing.com

Henry Schein Inc. (HSIC) stock reached a new 52-week high of $89.34, reflecting a 25.74% total return over the past year. This milestone follows strong first-quarter 2026 earnings, a strategic partnership with GoTu Technology to enhance dental staffing, and positive analyst upgrades from firms …

Henry Schein Inc. stock underperforms Thursday when compared to competitors despite daily gains

Shares of Henry Schein Inc. rose by 1.26% on Thursday, reaching $88.26, marking its sixth consecutive day of gains. Despite this increase, the stock underperformed compared to market competitors as the S&P 500 Index fell 0.51% and the Dow Jones Industrial Average fell 0.20% …

Here’s Why McKesson Corporation (MCK) Slid in Q2

McKesson Corporation (MCK) experienced a share price decline in Q2 2026, making it a detractor for the Janus Henderson Global Sustainable Equity Fund. The slide was attributed to a wider derating of drug distributors due to GLP-1 cash-pay concerns, a shift towards insurers, and …

Price to book forward of Cosmos Health Inc – SWB:V67A

This article provides a brief snapshot of the "Price to book forward" for Cosmos Health Inc (SWB:V67A) on the Stuttgart Stock Exchange. It indicates that the market was closed at the time of publication, with no trades reported. The content primarily highlights the financial …

ETFs Investing in McKesson Corporation Stocks

This article lists various Exchange Traded Funds (ETFs) that hold shares of McKesson Corporation (1MCK). It provides a detailed table including each fund's market value, weight of McKesson stock, issuer, management style, focus, expense ratio, assets under management (AUM), current price, daily percentage change, …

McKesson: Embedding Impact and Purpose Across Operations

McKesson's Fiscal Year 2026 Impact Report highlights the company's commitment to embedding impact across its operations, focusing on its people, partners, community, and planet. The report details achievements in strengthening healthcare logistics, expanding community access to care through initiatives like The US Oncology Network, …

McKesson (MCK) Publishes New Impact Report On Sustainability And Healthcare Delivery

McKesson (MCK) has released its Fiscal Year 2026 Impact Report, detailing its progress on sustainability, healthcare delivery, and stakeholder engagement. The report offers insights into the company's environmental goals and community support programs. This disclosure provides investors with a consolidated view of how McKesson …

Cencora stock reflects steady healthcare distribution role as investors track U.S. drug spending tre

Cencora Inc. plays a crucial role in the U.S. pharmaceutical supply chain as one of the largest distributors of drugs to healthcare providers. The company's business model is characterized by high volumes, tight logistics, and thin per-unit margins, making efficiency paramount. Investors monitor Cencora's …

Cosmos Health Share Buyback Surpasses 4.5 Million Shares; Continues Open Market Repurchases

Cosmos Health Inc. announced it has repurchased an additional 100,000 shares of its common stock, bringing the total repurchased under its program to 4,588,000 shares for approximately $970,000. The company plans to continue open market repurchases under the program, which is set to expire …

Henry Schein stock reflects steady healthcare distribution business

Henry Schein stock provides investors exposure to a global distributor of dental and medical supplies and technology solutions. The company's business model is characterized by recurring demand for consumables driven by ongoing patient care and a mixed revenue stream from both consumables and larger …

Is Cardinal Health’s (CAH) Specialty and Chronic-Care Pivot Quietly Rewiring Its Risk–Reward Profile?

Cardinal Health (CAH) is strategically shifting its business focus towards higher-growth, higher-margin specialty pharmaceuticals and chronic care services, including strong demand for oncology and GLP-1 products. This pivot aims to balance the company's traditional thin distribution margins and is supported by continued share repurchase …

Cosmos Health repurchases 100,000 shares at $0.29 average

Cosmos Health Inc. has repurchased 100,000 shares of its common stock at an average price of $0.2928 per share, bringing the total repurchases under its $5 million program to 4,588,000 shares. The company's CEO, Greg Siokas, emphasized commitment to the program, which is set …

How Cencora’s Revenue Miss Amid Growth Will Impact Cencora (COR) Investors

Cencora (COR) recently reported past-quarter revenues of US$78.36 billion, a 3.8% year-on-year increase, but this figure was 3.9% below analyst expectations. This revenue miss, despite overall growth, indicates potential challenges from ongoing margin pressures and evolving reimbursement frameworks, highlighting the importance of Cencora's investments …

Cosmos Health Has Spent About $970K on Open-Market Buybacks

Cosmos Health (NASDAQ: COSM) has repurchased an additional 100,000 shares of its common stock, bringing the total to 4,588,000 shares, for approximately $970,000 under its $5 million share repurchase program. The company continues to make open-market repurchases and the program is set to expire …

Video Forum: Matt Williams, McKesson

Matt Williams, vice president of U.S. government affairs at McKesson, discusses the company's efforts to support retail pharmacy through public policy. Key topics include the Main Street Pharmacy Access Act and the McKesson Amplify program, which provides resources to state pharmacy associations. This video …

Cheniere Appoints Former McKesson CFO Britt Vitalone to Board

Cheniere Energy has appointed Britt Vitalone, former Executive Vice President and Chief Financial Officer of McKesson, to its board of directors, effective July 14. Vitalone, who retired from McKesson earlier this year, brings over three decades of executive leadership and financial expertise to the …

ABGB Bond Profile — Key Metrics

This article provides key metrics for the ABGB bond, issued by Cencora, Inc. The bond is a 3.45% security maturing on December 15, 2027, with an outstanding amount of $750 million. Cencora, Inc. is a pharmaceutical sourcing and distribution company, operating through U.S. and …

McKesson breaks ground on $179 million Moore distribution center

McKesson has broken ground on a new $179 million, 330,000-square-foot regional distribution center in Moore, Oklahoma, replacing its existing facility. This highly automated center will expand capacity and efficiency, supporting over 200 jobs and strengthening McKesson's presence in the region. The project highlights Oklahoma's …

Cardinal Health’s 20.9% month splits from a weak Medical Distribution group

CAH finished 1.0% below its 52-week high after a 7.3% week on 13.1M shares, with trend and relative-strength evidence positive but activity pressure still only modest.

Why Is Henry Schein (HSIC) Up 4.6% Since Last Earnings Report?

Henry Schein, Inc. Just Recorded A 8.1% EPS Beat: Here's What Analysts Are Forecasting Next

Earnings Beat: Henry Schein, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Henry Schein Reports First Quarter 2026 Financial Results

HSIC Q1 Earnings & Revenues Surpass Estimates, Gross Margin Rises